Go Pro

Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group logo
$26.58 +0.21 (+0.81%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$26.64 +0.06 (+0.21%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MD vs. HIMS, CHE, BLLN, HNGE, and RDNT

Should you buy Pediatrix Medical Group stock or one of its competitors? Pediatrix Medical Group's main competitors and comparable companies include Hims & Hers Health (HIMS), Chemed (CHE), Billiontoone (BLLN), Hinge Health (HNGE), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Pediatrix Medical Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Pediatrix Medical Group (NYSE:MD) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

In the previous week, Hims & Hers Health had 51 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 56 mentions for Hims & Hers Health and 5 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.73 beat Hims & Hers Health's score of 0.00 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
8 Very Positive mention(s)
7 Positive mention(s)
21 Neutral mention(s)
12 Negative mention(s)
2 Very Negative mention(s)
Neutral
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Pediatrix Medical Group has a net margin of 8.96% compared to Hims & Hers Health's net margin of -5.51%. Pediatrix Medical Group's return on equity of 20.05% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-5.51% -6.51% -1.20%
Pediatrix Medical Group 8.96%20.05%8.15%

Hims & Hers Health has a beta of 2.4, suggesting that its stock price is 140% more volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

Hims & Hers Health presently has a consensus price target of $32.43, indicating a potential upside of 15.21%. Pediatrix Medical Group has a consensus price target of $24.83, indicating a potential downside of 6.58%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Pediatrix Medical Group has lower revenue, but higher earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.58B2.55$128.37M-$0.63N/A
Pediatrix Medical Group$1.91B1.13$165.39M$2.0912.72

Summary

Pediatrix Medical Group beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Chemed?

Pediatrix Medical Group (NYSE:MD) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Pediatrix Medical Group currently has a consensus target price of $24.83, indicating a potential downside of 6.58%. Chemed has a consensus target price of $530.75, indicating a potential downside of 0.58%. Given Chemed's higher possible upside, analysts plainly believe Chemed is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
Chemed
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17

Chemed has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B1.13$165.39M$2.0912.72
Chemed$2.60B2.69$265.24M$19.9126.81

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Pediatrix Medical Group had 3 more articles in the media than Chemed. MarketBeat recorded 5 mentions for Pediatrix Medical Group and 2 mentions for Chemed. Chemed's average media sentiment score of 1.76 beat Pediatrix Medical Group's score of 0.73 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Pediatrix Medical Group has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Pediatrix Medical Group's net margin of 8.96%. Chemed's return on equity of 31.77% beat Pediatrix Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group8.96% 20.05% 8.15%
Chemed 10.60%31.77%18.90%

Summary

Chemed beats Pediatrix Medical Group on 11 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Pediatrix Medical Group (NYSE:MD) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

97.7% of Pediatrix Medical Group shares are held by institutional investors. 50.2% of Billiontoone shares are held by insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Pediatrix Medical Group has higher revenue and earnings than Billiontoone. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.43$7.45M$0.70133.33
Pediatrix Medical Group$1.91B1.13$165.39M$2.0912.72

In the previous week, Billiontoone had 9 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 14 mentions for Billiontoone and 5 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.73 beat Billiontoone's score of 0.53 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
6 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Pediatrix Medical Group has a net margin of 8.96% compared to Billiontoone's net margin of 8.04%. Pediatrix Medical Group's return on equity of 20.05% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone8.04% 9.96% 5.35%
Pediatrix Medical Group 8.96%20.05%8.15%

Billiontoone presently has a consensus price target of $126.71, suggesting a potential upside of 35.77%. Pediatrix Medical Group has a consensus price target of $24.83, suggesting a potential downside of 6.58%. Given Billiontoone's stronger consensus rating and higher probable upside, equities research analysts clearly believe Billiontoone is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

Summary

Pediatrix Medical Group beats Billiontoone on 8 of the 15 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Hinge Health?

Pediatrix Medical Group (NYSE:MD) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Pediatrix Medical Group currently has a consensus price target of $24.83, suggesting a potential downside of 6.58%. Hinge Health has a consensus price target of $100.57, suggesting a potential upside of 14.06%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts clearly believe Hinge Health is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83

Pediatrix Medical Group has higher revenue and earnings than Hinge Health. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B1.13$165.39M$2.0912.72
Hinge Health$720.06M9.48-$528.26M$1.2868.89

In the previous week, Hinge Health had 4 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 9 mentions for Hinge Health and 5 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.73 beat Hinge Health's score of 0.40 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

97.7% of Pediatrix Medical Group shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Hinge Health has a net margin of 15.15% compared to Pediatrix Medical Group's net margin of 8.96%. Hinge Health's return on equity of 51.60% beat Pediatrix Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group8.96% 20.05% 8.15%
Hinge Health 15.15%51.60%14.16%

Pediatrix Medical Group has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

Summary

Hinge Health beats Pediatrix Medical Group on 12 of the 17 factors compared between the two stocks.

How does Pediatrix Medical Group compare to RadNet?

Pediatrix Medical Group (NYSE:MD) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

Pediatrix Medical Group currently has a consensus price target of $24.83, suggesting a potential downside of 6.58%. RadNet has a consensus price target of $88.00, suggesting a potential upside of 15.26%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
RadNet
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.89

Pediatrix Medical Group has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B1.13$165.39M$2.0912.72
RadNet$2.04B2.95-$18.65M-$0.27N/A

In the previous week, RadNet had 18 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 23 mentions for RadNet and 5 mentions for Pediatrix Medical Group. RadNet's average media sentiment score of 0.93 beat Pediatrix Medical Group's score of 0.73 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
10 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Pediatrix Medical Group has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market.

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Pediatrix Medical Group has a net margin of 8.96% compared to RadNet's net margin of -0.93%. Pediatrix Medical Group's return on equity of 20.05% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group8.96% 20.05% 8.15%
RadNet -0.93%2.61%0.91%

Summary

RadNet beats Pediatrix Medical Group on 10 of the 17 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MD vs. The Competition

MetricPediatrix Medical GroupHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$2.14B$9.82B$7.02B$24.31B
Dividend YieldN/A2.55%2.57%3.68%
P/E Ratio12.7235.17271.2730.85
Price / Sales1.135.37583.79137.34
Price / Cash11.80124.3470.4832.80
Price / Book2.453.9412.926.82
Net Income$165.39M$309.96M$3.45B$1.06B
7 Day Performance-1.67%0.09%1.15%0.55%
1 Month Performance2.41%-0.33%1.37%2.90%
1 Year Performance66.35%19.52%62.53%19.10%

Pediatrix Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MD
Pediatrix Medical Group
2.2239 of 5 stars
$26.58
+0.8%
$24.83
-6.6%
+71.0%$2.14B$1.91B12.724,315
HIMS
Hims & Hers Health
2.4266 of 5 stars
$31.39
+1.8%
$31.43
+0.1%
-40.3%$7.27B$2.35BN/A2,442
CHE
Chemed
4.1589 of 5 stars
$538.12
-0.5%
$530.75
-1.4%
+20.2%$7.13B$2.53B27.0015,811
BLLN
Billiontoone
4.4988 of 5 stars
$142.44
+3.7%
$126.00
-11.5%
N/A$6.53B$305.11M258.26620
HNGE
Hinge Health
3.5114 of 5 stars
$80.43
+3.6%
$86.07
+7.0%
+53.9%$6.22B$587.86MN/A1,437

Related Companies and Tools


This page (NYSE:MD) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners